Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience-Reference-Cited by-同舟云学术

Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

Published:2002-04 Issue:2 Volume:32 Page:110-122
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Valkema Roelf,de Jong Marion,Bakker Willem H.,Breeman Wout A.P.,Kooij Peter P.M.,Lugtenburg Pieternella J.,de Jong Frank H.,Christiansen Arjan,Kam Boen L.R.,de Herder Wouter W.,Stridsberg Mats,Lindemans Jan,Ensing Geert,Krenning Eric P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference41 articles.

1. [111In-DTPA-D-Phe1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation;Bakker;Life Sci,1991

2. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients;Krenning;Eur J Nucl Med,1993

3. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history;Krenning;Ann N Y Acad Sci,1994

4. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors;Janson;J Nucl Med,2000

5. Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy;De Jong;Nucl Med Commun,1998

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La radioligand therapy (RLT) nei tumori neuroendocrini;L'Endocrinologo;2024-09-10

2. Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-24

3. Targeted Radionuclide Therapy in Glioblastoma;ACS Applied Materials & Interfaces;2024-07-23

4. Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors;PET Clinics;2024-07

5. Immunological effects of radiopharmaceutical therapy;Frontiers in Nuclear Medicine;2024-04-04